Skip to main content
TipRanks
Go Ultimate75% OFF

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMEA) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has a market cap or net worth of EUR 29.68B. The enterprise value is EUR 45.26B.

Market Cap
EUR 29.68B
Enterprise Value
EUR 45.26B

Share Statistics

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has 1,406,570,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
1,406,570,700
Owned by Insiders
―
Owned by Institutions
<0.01%

Financial Efficiency

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 19.82%.

Return on Equity (ROE)
0.24
Return on Assets (ROA)
0.17
Return on Invested Capital (ROIC)
19.82%
Return on Capital Employed (ROCE)
0.26
Revenue Per Employee
508.14K
Profits Per Employee
136.92K
Employee Count
11,370
Asset Turnover
0.64
Inventory Turnover
2.43

Valuation Ratios

The current PE Ratio of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is 21.70. Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s PEG ratio is 1.80.

PE Ratio
21.70
PS Ratio
5.85
PB Ratio
5.73
Price to FCF
11.78
Price to Operating Cash Flow
10.92
PEG Ratio
1.80

Income Statement

In the last 12 months, Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh had revenue of 5.78B and earned 1.56B in profits. Earnings per share was 1.07.

Revenue
5.78B
Gross Profit
3.48B
Operating Income
1.96B
Pretax Income
1.96B
Net Income
1.56B
EBITDA
2.21B
Earnings Per Share (EPS)
1.07

Cash Flow

In the last 12 months, operating cash flow was 1.76B and capital expenditures -161.37M, giving a free cash flow of 1.60B billion.

Operating Cash Flow
1.76B
Free Cash Flow
1.60B
Free Cash Flow per Share
19.92

Dividends & Yields

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh pays an annual dividend of ―, resulting in a dividend yield of 1.07%

Dividend Per Share
―
Dividend Yield
1.07%
Payout Ratio
N/A
Free Cash Flow Yield
8.49%
Earnings Yield
4.67%

Stock Price Statistics

Beta
0.44
52-Week Price Change
-3.77%
50-Day Moving Average
19.82
200-Day Moving Average
18.71
Relative Strength Index (RSI)
49.16
Average Volume (3m)
270

Important Dates

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh upcoming earnings date is Jan 28, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 29, 2026
Next Earnings Date
Jan 28, 2027
Ex-Dividend Date
―

Financial Position

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh as a current ratio of 3.10, with Debt / Equity ratio of 12.54%

Current Ratio
3.10
Quick Ratio
2.42
Debt to Market Cap
0.02
Net Debt to EBITDA
-0.29
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has paid 404.82M in taxes.

Income Tax
404.82M
Effective Tax Rate
0.21

Enterprise Valuation

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh EV to EBITDA ratio is 14.80, with an EV/FCF ratio of 11.64.

EV to Sales
5.78
EV to EBITDA
14.80
EV to Free Cash Flow
11.64
EV to Operating Cash Flow
10.62

Balance Sheet

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has EUR 1.01B in cash and marketable securities with EUR 608.91M in debt, giving a net cash position of EUR 399.07M billion.

Cash & Marketable Securities
EUR 1.01B
Total Debt
EUR 608.91M
Net Cash
EUR 399.07M
Net Cash Per Share
EUR 0.28
Tangible Book Value Per Share
EUR 1.80

Margins

Gross margin is 61.18%, with operating margin of 33.13%, and net profit margin of 27.79%.

Gross Margin
61.18%
Operating Margin
33.13%
Pretax Margin
35.09%
Net Profit Margin
27.79%
EBITDA Margin
39.07%
EBIT Margin
35.09%

Analyst Forecast

The average price target for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is EUR 24.22, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
EUR 24.22
Price Target Upside
18.75% Upside
Analyst Consensus
Moderate Buy
Analyst Count
7
Revenue Growth Forecast
3.63%
EPS Growth Forecast
6.61%

Scores

Smart Score
9
AI Score
―